{"id":31732,"date":"2016-11-06T06:46:57","date_gmt":"2016-11-06T14:46:57","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/11\/researcher-develops-safer-gene-therapy"},"modified":"2017-06-04T14:04:54","modified_gmt":"2017-06-04T21:04:54","slug":"researcher-develops-safer-gene-therapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/11\/researcher-develops-safer-gene-therapy","title":{"rendered":"Researcher develops safer gene therapy"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/researcher-develops-safer-gene-therapy.jpg\"><\/a><\/p>\n<p>More progress with gene therapy safety.<\/p>\n<hr>\n<p>A Washington State University researcher has developed a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy.<\/p>\n<p>Grant Trobridge, an associate professor of pharmaceutical sciences, has altered the way a virus carries a beneficial gene to its <a href=\"http:\/\/medicalxpress.com\/tags\/target+cell\/\" rel=\"tag\" class=\"\">target cell<\/a>. The modified viral vectors reduce the risk of cancer and can be used for many blood diseases.<\/p>\n<p>Trobridge and his team report their development in <i>Scientific Reports<\/i>, an online open-access journal produced by the Nature Publishing Group. The team is translating their findings into a stem cell gene therapy to target a life-threatening immunodeficiency in newborns called SCID-X1, also known as \u201cBoy in the Bubble Syndrome.\u201d<\/p>\n<p><!-- Link: <a href=\"http:\/\/medicalxpress.com\/news\/2016-11-safer-gene-therapy.html\">http:\/\/medicalxpress.com\/news\/2016&#45;11-safer-gene-therapy.html<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>More progress with gene therapy safety. A Washington State University researcher has developed a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy. Grant Trobridge, an associate professor of pharmaceutical sciences, has altered the way a virus carries a beneficial gene to its target cell. The [\u2026]<\/p>\n","protected":false},"author":370,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-31732","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/31732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/370"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=31732"}],"version-history":[{"count":2,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/31732\/revisions"}],"predecessor-version":[{"id":65830,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/31732\/revisions\/65830"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=31732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=31732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=31732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}